The new pandemic leaves us in dire need of information. How can I protect myself and my unborn baby? How high is the risk of a COVID-19 infection for preterm born babies? How can I prepare the discharge of my preterm born baby? These are just a few of the questions that occupy parents and parents-to-be at the moment.  Together with experts for Neonatology as well as Obstetrics and Gynecology we developed questions and answers about COVID-19 concerning maternal and newborn health. This FAQ (Frequently Asked Questions) is intended to be a guide but cannot and should not be a substitute for in-depth discussion with your doctor, midwife or nurse. Please make a note of any questions you may have on the subjects covered in this FAQ for your doctor, midwife or nurse, to answer at your next appointment.

For extensive, valid and up-to-date information about COVID-19 please visit the website of your national, regional or local governmental health institutions or the World Health Organization (WHO). The WHO website provides information in several languages.

The FAQ could not have been finalised, without the kind support of Professor Christoph Bührer, Medical Director Department of Neonatology, Charité Berlin and Doctor Dietmar Schlembach, Head of Department of Obstetrics and Gynaecology at Vivantes Clinic Berlin-Neukölln.

You can find the FAQ about COVID-19 concerning maternal and newborn health on the website of GLANCE the Global Alliance for Newborn Care, a new global initiative, founded and coordinated by EFCNI.

For further information about COVID-19 you might also want to read the following articles:

COVID-19 Survey

Impact of Coronavirus/COVID-19 on special/intensive care for newborns – a parents’ perspective”

The Coronavirus/COVID-19 pandemic creates exceptional challenges, especially for the care of the most vulnerable groups of patients – such as sick and preterm born children. It is therefore important to explore parents’ experiences related to these challenges as they play a crucial role in the care of their babies – not only at home but also in the hospital setting. Having unique insights into the perceived problems will help identify the strengths and weaknesses of the care provision in the context of crisis response. Finally, conclusions can be drawn for future emergencies and the impact on neonatal care.

This research is a joint initiative by EFCNI and GLANCE. It is carried out by the Scientific Affairs Department of EFCNI in collaboration with representatives of parent organisations, COINN (Council of International Neonatal Nurses), ESPR (European Society for Paediatric Research), NIDCAP (Newborn Individualized Developmental Care and Assessment Program), and UENPS (Union of European Neonatal & Perinatal Societies).

We would like to express our greatest appreciation to those who supported us with translating the survey. Numerous members of parent organisations and healthcare professionals have volunteered to make this study available in 23 languages. Thank you!

The Ethics Committee of Maastricht UMC+ officially waived the need for ethics approval.

EFCNI received an earmarked donation by Novartis Pharma AG in support of this study.

For further information, please visit or contact:

Please note the survey is closed, has been evaluated, and results and findings will be published in autumn 2021. First research findings have been published recently. Additional updates will be continuously announced in the EFCNI newsletter and published on our website. For a recent update read our latest news.